Similarly, higher elevated levels of CXCL8 have been observed in the serum and tumor tissues in patients with Kras mutant-pancreatic and lung cancer (Wigmore et al., 2002; Tas et al., 2006; Frick et al., 2008). The gene discussed is KRAS; the disease is neoplasm.